Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

This is a collection of current resources related to Nirsevimab.

8190 of over 100 results
Preventing RSV in Babies: A Scientific Milestone
2023 · Children's Hospital of Philadelphia
This 3-minute video discusses the use of nirsevimab (Beyfortus™) to protect vulnerable infants from RSV. Dr. Paul Offit explains its benefits, clinical trial results, and …
Respiratory Syncytial Virus (RSV) Vaccines and Therapeutics
2024 · American Academy of Family Physicians
This webpage provides guidance and resources on respiratory syncytial virus (RSV) and immunization. RSV is a common lung virus that mainly affects young children under …
Beyfortus (nirsevimab) Now Available Through VFC
2024 · Philadelphia Department of Public Health
This announcement explains that providers can order nirsevimab (Beyfortus) through Vaccines for Children (VFC). It covers the following areas of consideration: dosage and administration, eligible …
5 Tips on Buying Beyfortus (nirsevimab-alip) for Babies
2024 · PracticeWell
This webpage explains how to order Beyfortus, a monoclonal antibody that may prevent young infants from getting respiratory syncytial virus (RSV). It covers discounts, reimbursements, …
Nirsevimab Informational Webinar
2023 · Washington Chapter of the American Academy of Pediatrics (WCAAP)
This webinar provides guidance on ordering and administering nirsevimab, a monoclonal antibody for preventing severe RSV in infants. Presenters represent the Washington Chapter of the …
ACOG, SMFM, and AAP Statement on Nirsevimab Shortage
2023 · American College of Obstetricians and Gynecologists
This statement describes a shortage of nirsevimab and provides further recommendations. ACOG and SMFM recommend Pfizer’s RSVpreF vaccine for pregnant women as an alternative. Pediatricians …
Protecting Young Children From RSV: Nirsevimab Medicine Provides Extra Layer of Protection
· Memorial Hermann
This webpage features responses to 10 frequently asked questions (FAQs) that parents ask about RSV and nirsevimab. It also addresses proper hand hygiene. Nirsevimab, along …
Nirsevimab Monoclonal Antibody Memo (2024-2025)
2024 · Lucile Packard Children's Hospital Stanford
This memo outlines recommendations and an implementation plan for nirsevimab (Beyfortus™), a long-acting monoclonal antibody effective against respiratory syncytial virus (RSV), at Lucile Packard Children’s …
Impact of Nirsevimab on Admission to a Spanish Pediatric Intensive Care Unit Because of RSV Bronchiolitis: Unicentric Observational Study from 2017 to 2024
2024 · Hospital Infantil Universitario Niño Jesús
This letter describes admissions to a pediatric critical care unit (PICU) because of acute bronchiolitis caused by respiratory syncytial virus. The study looked at a …
Nirsevimab (Beyfortus) Guide to Prevent Severe RSV in Infants and Toddlers
2023 · California Department of Public Health
This one-page infographic provides guidance on using nirsevimab (Beyfortus) to prevent severe RSV in infants and toddlers. It addresses high-risk conditions in children, as well …

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie
8190 of over 100 results